RFK Jr.’s stock portfolio was a mystery for a long time. The one-time independent presidential candidate and Donald Trump’s nominee for Secretary of Health and Human Services did not voluntarily publish its contents during his run for the White House — although the disclosures he was required to file did give a small glimpse into his holdings.
As a scion of one of America’s wealthiest families and a successful lawyer, it stands to reason that Kennedy invests in the financial markets. That thesis was confirmed on January 21 — as Robert F. Kennedy Jr. had to disclose his holdings to the Office of Government Ethics on account of his nomination to a high-ranking cabinet position.
A significant portion of RFK’s investments are in private equity, exchange-traded funds (ETFs), and money market funds, but he does seem to have somewhat of an appetite for riskier assets — as demonstrated by his stock and cryptocurrency holdings.
RFK Jr.’s portfolio holds Bitcoin, big tech, and biotech stocks
Per the filing, Robert F. Kennedy’s largest publicly traded holding is Amazon (NASDAQ: AMZN). The presumptive Health Secretary owns between $15,001 and $50,000 worth of AMZN stock. In addition, RFK holds between $1,001 and $15,000 in Apple (NASDAQ: AAPL) stock.
However, his largest holding by far is Bitcoin (BTC) — back in November of 2024, the cabinet nominee revealed that he had put most of his wealth in the digital asset — referring to it as the ‘currency of freedom.’
A staunch advocate, Kennedy had at one point even accused members of Congress of being paid to ban the cryptocurrency. At present, his BTC stake is valued at $1,000,001 to $5,000,000.
RFK Jr. bought BTC in May of 2023 following his speech at the Bitcoin 2023 conference in Miami. The exact timing of the purchase was not known — but since the conference took place from May 18 to May 20, 2023, a time when Bitcoin was trading at a price of roughly $27,118, Kennedy accrued significant returns from his crypto position, as the price of BTC has increased by 276.96% since then.
In addition, RFK’s healthcare skepticism doesn’t appear to extend to gene editing — as the filing reveals a $1,001 to $15,000 stake in CRISPR Therapeutics AG (NASDAQ: CRSP).
Interestingly enough, although the environmental activist has pledged to divest from his stock holdings, he hasn’t made the same promise when it comes to his cryptocurrency assets. On January 29, the Senate Finance Committee will hold a hearing to consider RFK’s nomination. The meeting will likely see a further examination of potential conflicts of interest, as well as Kennedy’s divestment plans.
Featured image via Shutterstock
